Physician

Scott A Limstrom, MD

According to 2025 Medicare claims, Scott Limstrom, MD (NPI: 1366421885) practices ophthalmology in the Anchorage, AK market, with the plurality of this provider's patient population coming from Anchorage, AK. This provider's primary affiliated billing organization is ALASKA RETINAL CONSULTANTS (NPI: 1003934340; TIN: 920147885) and primary practice location at 99518-1641.

Limstrom's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,582 traditional Medicare patients, billed 50,400 HCPCS/CPT codes, and received $3,655,571 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 884 prescription claims across 211 beneficiaries totaling $44,036 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 11 records totaling $439. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $718,947 to $3,655,571. Similarly, Part D prescription costs have risen steadily, from $22,041 to $44,036. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.8M$3.7M2015 Medicare payment: $718,947 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $668,905 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $940,777 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,383,509 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,271,076 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,566,126 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,832,110 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,009,184 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,273,476 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,655,571 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,1234,486$718,947
20168763,594$668,905
20171,0154,479$940,777
20181,1586,118$1,383,509
20191,1295,563$1,271,076
20201,0646,706$1,566,126
20211,0387,227$1,832,110
20221,1509,761$2,009,184
20231,55933,103$3,273,476
20241,58250,400$3,655,571

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$28K$57K2015 Drug cost: $22,041 (USD; Tot_Drug_Cst)2016 Drug cost: $24,662 (USD; Tot_Drug_Cst)2017 Drug cost: $23,176 (USD; Tot_Drug_Cst)2018 Drug cost: $19,181 (USD; Tot_Drug_Cst)2019 Drug cost: $33,934 (USD; Tot_Drug_Cst)2020 Drug cost: $30,418 (USD; Tot_Drug_Cst)2021 Drug cost: $29,614 (USD; Tot_Drug_Cst)2022 Drug cost: $36,845 (USD; Tot_Drug_Cst)2023 Drug cost: $56,858 (USD; Tot_Drug_Cst)2024 Drug cost: $44,036 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201598286$22,041
201694273$24,662
201788293$23,176
2018106332$19,181
2019149487$33,934
2020145440$30,418
2021123522$29,614
2022186727$36,845
2023205897$56,858
2024211884$44,036

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye5591,912$117
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more442632$114
92014Established patient complete exam of visual system389391$95
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more565867$76
92134Imaging of retina1,4753,343$35

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine15495$9,719
Prednisolone AcetatePrednisolone Acetate2016,026$7,045
Ketorolac TromethamineKetorolac Tromethamine2516,689$6,896
Loteprednol EtabonateLoteprednol Etabonate22727$3,488
Brimonidine TartrateBrimonidine Tartrate15547$1,216

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.11$439Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Scott A. Limstrom, MD?

Tedicare shows public-source Medicare data for Scott A. Limstrom, MD (NPI 1366421885), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Scott A. Limstrom, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Scott A. Limstrom, MD?

Scott A. Limstrom, MD is linked to ALASKA RETINAL CONSULTANTS (billing NPI 1003934340) in the available physician profile data.

Does Scott A. Limstrom, MD have Open Payments data?

Scott A. Limstrom, MD has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.